• Info
  • Insider Ownership

Insider Trading & Ownership of Stephen L. Huhn

Location
San Diego, CA
Summary
The estimated net worth of Stephen L. Huhn is at least $218,240 dollars as of 31 Jan 2025. Stephen L. Huhn is the CMO & Sr VP, Clinical Dev. of Contineum Therapeutics, Inc. and owns shares of Contineum Therapeutics, Inc. (CTNM) stock worth about $218.2K.
Signature
/s/ Peter Slover, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Stephen L. Huhn files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Stephen L. Huhn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CTNM Contineum Therapeutics, Inc. CMO & Sr VP, Clinical Dev. $218,240 31 Jan 2025

Insider Transactions Reported by Stephen L. Huhn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.